Specific characteristics of STEMI in COVID-19 patients and their practical implications
Mauro Gitto1,2, Laura Novelli3,4, Bernhard Reimers3,4
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Milan, Italy. giulio.stefanini@hunimed.eu.
Insights
The COVID-19 pandemic complicated ST-elevation myocardial infarction (STEMI) care, worsening outcomes for patients with SARS-CoV-2. This review covers myocardial injury, clinical features, and management challenges for STEMI patients during the pandemic.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- ST-elevation myocardial infarction (STEMI) management is critically challenged by the COVID-19 pandemic.
- Co-infection with SARS-CoV-2 presents unique obstacles including self-isolation, systemic inflammation, and delayed treatment.
- These factors have diminished recent advancements in STEMI care, negatively impacting patient prognosis.
Purpose of the Study:
- To review the mechanisms of myocardial injury in STEMI patients with COVID-19.
- To outline specific clinical and angiographic characteristics of this patient cohort.
- To discuss contemporary management strategies and their implications for in-hospital mortality and short-term outcomes.
Main Methods:
- Literature review of studies focusing on STEMI and COVID-19.
- Analysis of mechanisms contributing to myocardial injury.
- Synthesis of clinical presentation, diagnostic challenges, and treatment approaches.
Main Results:
- COVID-19 exacerbates STEMI complexity through inflammation and treatment delays.
- Specific clinical and angiographic patterns are observed in STEMI patients with SARS-CoV-2.
- Management strategies must adapt to the dual threat of myocardial infarction and viral infection.
Conclusions:
- The pandemic has significantly impaired outcomes for STEMI patients with COVID-19.
- Understanding the interplay between STEMI and SARS-CoV-2 is crucial for improving care.
- Timely diagnosis and tailored management are essential to mitigate increased mortality.
Abstract:
ST-elevation myocardial infarction (STEMI) is one of the cardiac emergencies whose management has been most challenged by the COVID-19 pandemic. Patients presenting with the "lethal combo" of STEMI and concomitant SARS-CoV-2 infection have faced dramatic issues related to the need for self-isolation, systemic inflammation with multi-organ disease and difficulties to obtain timely diagnosis and treatment. The interplay between these and other factors has partly neutralized the major advances in STEMI care achieved in the last decades, significantly impairing prognosis in these patients. In the present review article, we will provide an overview on mechanisms of myocardial injury, specific clinical and angiographic characteristics and contemporary management in different settings of STEMI patients with COVID-19, alongside the inherent implications in terms of in-hospital mortality and short-term clinical outcomes.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:14Myocarditis III: Medical Management
01:27Myocarditis II: Clinical Features and Diagnostic Tests